Your Trusted Pet Drug Development Partner
Who We Are
In today's society, pets have long become indispensable members of most families. Pet owners are increasingly prioritizing their pets' health, leading to a rapidly growing demand for safe, effective, and user-friendly pet drugs. However, successfully bringing a new pet drug from the laboratory to the market is a journey fraught with challenges, involving complex basic research, strict regulatory compliance, precise manufacturing processes, and substantial resource investment.
As a globally leading pet drug CRO/CDMO, Protheragen Vetivio deeply understands the uniqueness and complexities of pet drug development. We provide comprehensive services covering the entire pet drug lifecycle, accelerating the market availability of safe and effective pet medications, extending pets' healthy lifespan, and enhancing their quality of life.
Meet Our Team
Research & Development Team
We have world-class veterinary pharmacologists, toxicologists, medicinal chemists, and formulation scientists. They possess deep knowledge of species-specific physiology and disease mechanisms, developing safe, effective drug candidates tailored for pets.
Process Development & Manufacturing Team
We have expert process chemists, analytical scientists, formulation specialists, and manufacturing professionals. They master the transition from lab-scale to commercial production, ensuring scalability, efficiency, and unwavering quality control.
Clinical Research Team
Our experienced pet clinical research scientists, monitors, and data managers. They design and execute robust clinical trials in target species, generating the high-quality data essential for demonstrating safety and effectiveness in real-world settings.
Regulatory Affairs Team
Our seasoned regulatory team provides strategic guidance from the earliest stages of pet drug development, crafting robust submission packages and ensuring compliance to mitigate risks and significantly shorten your time to market.